Form 4 for GILD Gilead Sciences
Accepted 2026-09-16 16:30:47 ET · period of report 2026-09-15 · accession 0001310204-26-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 16:30 | 2026-09-15 | GILD | Dickinson Andrew D | CFO | S - Sale | $145.29 | -3,000 | 164.1K | -2% | -$435.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | S | D | 3,000 | $145.29 | 164,096 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. |